# Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.

> **NCT06928883** · NA · NOT_YET_RECRUITING · sponsor: **Cardiocentro Ticino** · enrollment: 24 (estimated)

## Conditions studied

- Coronary Arterial Disease (CAD)
- Vulnerable Coronary Plaques
- Multivessel Coronary Artery Disease
- Coronary Vessel
- Acute Coronary Syndromes (ACS)

## Interventions

- **DEVICE:** Sirolimus drug eluting ballooon therapy
- **DRUG:** Optimal guidelines-directed medical therapies (GDMT)

## Key facts

- **NCT ID:** NCT06928883
- **Lead sponsor:** Cardiocentro Ticino
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06928883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06928883, "Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06928883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*